Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VIGAFYDE safely and effectively. See full prescribing information for VIGAFYDE . VIGAFYDE ® ( vigabatrin ) oral solution Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
VIGAFYDE is indicated as monotherapy for the treatment of infantile spasms in pediatric patients 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss [see Warnings and Precautions ( 5.1 )].
- generic_name
- vigabatrin
- product_names
- vigabatrin
- ndc
- 80789-003, 80789-003-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en